GERALDINE JONES: Open Payments
NPI 1770899262 · CORDELE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 39 payments from 16 companies in 2025. Trend: 2023 $1,289 · 2024 $952 · 2025 $714
Food & beverage: $709Education: $5
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $95 |
| Ardelyx, Inc. | 3 | $85 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Merck Sharp & Dohme LLC | 3 | $58 |
| Amgen Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 4 | $28 |
Products named: Kerendia, IBSRELA, TRELEGY ELLIPTA, Wegovy, Ozempic, VERQUVO, FARXIGA, LEQVIO.
Industry payments across GA — which companies pay providers there.
